Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543

Biochemical and Biophysical Research Communications
TongFa JuZheng-Yu Fang

Abstract

In this study, we showed that PF-543, a novel sphingosine kinase 1 (SphK1) inhibitor, exerted potent anti-proliferative and cytotoxic effects against a panel of established (HCT-116, HT-29 and DLD-1) and primary human colorectal cancer (CRC) cells. Its sensitivity was negatively associated with SphK1 expression level in the CRC cells. Surprisingly, PF-543 mainly induced programmed necrosis, but not apoptosis, in the CRC cells. CRC cell necrotic death was detected by lactate dehydrogenase (LDH) release, mitochondrial membrane potential (MMP) collapse and mitochondrial P53-cyclophilin-D (Cyp-D) complexation. Correspondingly, the necrosis inhibitor necrostatin-1 largely attenuated PF-543-induced cytotoxicity against CRC cells. Meanwhile, the Cyp-D inhibitors (sanglifehrin A and cyclosporin A), or shRNA-mediated knockdown of Cyp-D, remarkably alleviated PF-543-induced CRC cell necrotic death. Reversely, over-expression of wild-type Cyp-D in HCT-116 cells significantly increased PF-543's sensitivity. In vivo, PF-543 intravenous injection significantly suppressed HCT-116 xenograft growth in severe combined immunodeficient (SCID) mice, whiling remarkably improving the mice survival. The in vivo activity by PF-543 was largely attenuate...Continue Reading

References

Jan 12, 2000·Experimental Neurology·P G SullivanS W Scheff
Mar 21, 2006·Biochemical Society Transactions·A P Halestrap
Jul 22, 2008·Biochimica Et Biophysica Acta·Mathew VadasJennifer Gamble
Aug 12, 2008·Current Drug Targets·Dai ShidaSarah Spiegel
Oct 1, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Toshihiko KawamoriLina M Obeid
Jun 22, 2012·PloS One·Sebastián ZamoranoClaudio Hetz
Aug 16, 2012·Biochemical and Biophysical Research Communications·Chao JiZhi-Gang Bi
Feb 6, 2013·Nature Reviews. Clinical Oncology·Ernst J KuipersMichael Bretthauer
Mar 30, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·John W Elrod, Jeffery D Molkentin
Apr 10, 2013·Nature Reviews. Gastroenterology & Hepatology·Antoine Brouquet, Bernard Nordlinger
Jul 13, 2013·Biochemical and Biophysical Research Communications·Bo ChenTu Dai
Jan 22, 2014·Nature Reviews. Clinical Oncology·Hans-Joachim Schmoll, Alexander Stein
Apr 17, 2014·Biochemical and Biophysical Research Communications·Ying QiuHui Sun
May 31, 2015·Journal of Experimental & Clinical Cancer Research : CR·Li-sen QinShi-ming Zhang
Oct 3, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chunxian ZhouDongfeng Xu

❮ Previous
Next ❯

Citations

Apr 23, 2016·Biochemical and Biophysical Research Communications·Feng GuoLong-Yang Zhang
Jun 15, 2016·Cellular Signalling·Melissa R PitmanStuart M Pitson
Nov 2, 2016·Frontiers in Oncology·Yamila I RodriguezSergio E Alvarez
Jun 18, 2017·Science China. Life Sciences·Zuoquan XieMeiyu Geng
Oct 11, 2017·International Journal of Molecular Sciences·Yonghua BaoWancai Yang
Dec 23, 2017·Mediators of Inflammation·Nitai C Hait, Aparna Maiti
Nov 18, 2017·Nature Reviews. Cancer·Besim Ogretmen
Sep 22, 2018·Cancer Science·Masayuki NagahashiToshifumi Wakai
Nov 23, 2017·Nature Reviews. Molecular Cell Biology·Yusuf A Hannun, Lina M Obeid
May 31, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Su Bin KimEun-Young Park
Jul 8, 2017·Cancer Biology & Therapy·E Ramsay CampChristina Voelkel-Johnson
Jun 13, 2020·Frontiers in Oncology·Alexander KrollMin H Kang
Jun 4, 2019·Chemical & Pharmaceutical Bulletin·Seon Woong KimEun-Young Park
Apr 6, 2019·Current Pharmaceutical Design·Elisa MagliBeatrice Severino
May 28, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Petra Grbčić, Mirela Sedić
Nov 23, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Faez Iqbal KhanMohd Kalim Ahmad Khan
Jan 18, 2021·European Journal of Medicinal Chemistry·Tiandi DingBo Liu
Apr 8, 2021·Cell Death & Disease·Ying-Chen XiaBen-Tong Yu
Jul 11, 2021·Cellular Signalling·Real Sumayya Abdul SattarSundeep Singh Saluja
May 22, 2020·ACS Medicinal Chemistry Letters·Athanasios PapakyriakouBarbara Richichi
Oct 15, 2021·The Biochemical Journal·Botheina GhandourNadine Darwiche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Chunxian ZhouDongfeng Xu
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Shang MinjieZhang Yuhua
Biochemical and Biophysical Research Communications
Min-Bin ChenYe Tian
© 2022 Meta ULC. All rights reserved